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ABSTRACT 
 
 Herbal teas are widely consumed for their valuable content on phytochemicals with 
antioxidant properties. This work represents the first attempt to establish a linkage 
between the chemical composition of Mentha pulegium L. infusion and its potential to 
prevent oxidative stress in cells. The phenolic profile was established by HPLC-DAD-
ESI/MSn, 12 out of 15 compounds being identified for the first time in this species. The 
infusion presented a total phenolic content of 122.92 mg/g (lyophilized extract), also 
demonstrated a remarkable antiradical activity against DPPH· (EC50= 39 µg/mL), O2·- 
(EC50= 23 µg/mL) and ·NO (EC50= 226 µg/mL) radicals. It also revealed to be very 
effective in protecting AGS and Caco-2 cell lines against tert-butylhydroperoxide induced 
toxicity as evaluated by the MTT assay, under a pre-treatment experimental model. 
Reduced glutathione detoxification mechanism was demonstrated to be involved in Caco-
2 cells resistance, while the same was not observed for AGS cells. The presence of 
phenolic compounds inside the cells, after infusion removal, was confirmed by DPBA 
phenol fluorescence dye staining. A direct antioxidant effect can contribute to the 
observed protective effect. Attending to all the results here presented, the consumption of 
M. pulegium infusion provides bioactive compounds with great importance to the 
maintenance of a proper antioxidant imbalance in gastrointestinal cells.      
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RESUMO 
 
 As plantas medicinais são amplamente consumidas, uma vez que representam 
uma vasta fonte de compostos com ação antioxidante. Neste trabalho foi explorada pela 
primeira vez a ligação entre a composição química da espécie Mentha pulegium L. e a 
capacidade para prevenir o stress oxidativo celular. O perfil fenólico foi estabelecido por 
HPLC-DAD-ESI/MSn e 12 dos 15 compostos identificados foram descritos pela primeira 
vez nesta espécie. A infusão apresentou um teor fenólico total de 122.92 mg/g (extrato 
liofilizado) e demonstrou grande atividade contra os radicais DPPH· (EC50= 39 µg/mL), 
O2·- (EC50= 23 µg/mL) e ·NO (EC50= 226 µg/mL). O pré-tratamento de células AGS e 
Caco-2 com a infusão, seguido de exposição ao terc-butil-hidroperóxido, revelou a sua 
eficiência na proteção contra a toxicidade induzida pelo agente agressor, aferida pelo 
ensaio de redução do MTT. A destoxificação pela glutationa reduzida demonstrou ser 
determinante para a resistência verificada nas células Caco-2, não se observando o 
mesmo relativamente às células AGS. Recorrendo à marcação por fluorescência de 
compostos fenólicos com DPBA foi confirmado que estes se encontravam dentro das 
células aquando da exposição ao agente agressor, sugerindo a contribuição de um efeito 
direto na proteção mediada pela infusão. Considerando todos os resultados aqui 
apresentados pode-se concluir que a ingestão da infusão de M. pulegium fornece 
compostos bioativos com particular interesse para a manutenção do equilíbrio 
antioxidante de células gastrointestinais. 
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1. Phytotherapy 
 
Medicinal plants are used as pharmacotherapy tools worldwide. Since remote times, 
different species were selected and applied to prevention and treatment of diverse 
pathologies. This ancient practice has been replaced by modern medicine brought with 
the 20th century. But it is a fact that for approximately 80% of world’s population, 
phytotherapy constitutes the first line of treatment, often being the only one existing. 
Moreover, in 1978 the World Health Organization recognized Traditional Medicine as a 
valid form of primary healthcare, being continuously working towards its regulation and 
correct use (1). 
Nature is a huge source of chemical compounds with pharmacologic and toxic 
activities, also having a key role in the development of novel synthetic drugs. In the past 
thirty years, major contributions have been made to diverse fields, such as 
neurodegenerative diseases, cancer treatment and anti-inflammatory agents (2). 
A revivalist trend as recently brought back phytotherapy to the spotlight. All over 
Europe this market has shown a big expansion, particularly in Germany, France and Italy 
(3). New approaches to Traditional Medicine, based on reverse-pharmacology, seem to 
allow the perfect linkage between popular knowledge, science and the positive health 
outcomes for consumers (4). Moreover the easy access, low prices, strong marketing and 
the wrong popular idea of absence of associated risks are the main boosters behind this 
consumption’s growth. These products are presented in pharmaceutical dosage forms like 
capsules, tablets and drops. More traditional forms can also be found at herbal stores (5). 
Medicinal plants are currently applied to cure and prevent respiratory, gastrointestinal and 
sleep disorders, to alleviate side effects of anticancer therapies, to fight depression, to 
enhance weight loss and dietary supplementation, in dermatology and cosmetics, among 
other uses (6). 
Such impact on public health justifies, per se, the need to understand and study, not 
only the chemical composition of these products, but also the risks and benefits resulting 
from their consumption. The increasing number of reports on interactions between herbal 
medicines and prescribed drugs reflects this reality. Additionally, adulteration of final 
products, misidentification of species, heavy metals contamination and the presence of 
pesticides are safety issues that must be taken into consideration (7). These events are 
complex to elucidate and have the disadvantage of both qualitative and quantitative 
variation of the chemical profile of the natural species, due to different growing conditions 
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and industrial and storage processes (8). For all the reasons presented above the 
pharmacological and toxic potentials of medicinal plants is an important and vast field for 
scientists to explore. 
 
2. Cellular oxidative stress 
 
A homeostatic cell environment is necessary to maintain proper physiological 
functions. A vast number of free radicals, resulting from both endogenous processes and 
exogenous sources, is responsible for the significant alteration of cellular homeostasis, 
leading to oxidative stress. Nevertheless, their physiological roles cannot be 
underestimated (9). As examples, reactive oxygen species (ROS) include either oxygen 
radicals like superoxide (O2·-), hydroxyl (·OH), and peroxyl (RO2·) radicals, or non-radical 
oxidizing agents, such as hydrogen peroxide (H2O2) and hypochlorous acid (HOCl), easily 
converted into radicals. Also, reactive nitrogen species (RNS) and reactive sulfur species 
(RSS), which are formed by thiols’ reaction with ROS, play an active role in disrupting the 
imbalance between pro-oxidants and antioxidants. 
The interest on these radical species has been increasing, since they are thought 
to be involved in different pathophysiological mechanisms behind neurodegenerative and 
cardiovascular diseases, diabetes, arthritis, osteoporosis and cancer (10). 
The cellular damage depends on the doses and time of ROS exposure, triggering 
different pathways and modulating the action of enzymes and transcription factors. 
Diverse effects can be observed, from cellular proliferation by mitogenic stimulation in low 
doses, to cellular cycle arresting or even cellular death by apoptosis or necrosis when 
exposed to high doses (Fig. 1).  
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Figure 1. Sources of radical species and possible cellular responses. The oxidative imbalance results 
from the simultaneous presence of endogenous or exogenous ROS and enzymatic antioxidant defenses like 
catalase (CAT), superoxide dismutase (SOD) glutathione peroxidase (GPx) or non-enzymatic like glutathione. 
Diverse defensive mechanisms can be triggered leading to a proliferative decrease up to cell death (adapted 
from (10)). 
  
While some of the pathways enhance cell survival, others are associated with cell 
death and many of them can act both ways depending on the circumstances (Table 1). 
However, it is important to understand that the ultimate response is a result of an 
integration of multiple stimuli (11). 
 
Table 1. Examples of ROS activated pathways and their contribution to the cellular outcome. From (11). 
  Cellular outcomeb 
Signaling pathwaysa  Enhanced survival  Cell death 
      
p53  +  +++ 
NFkB  +  +++ 
HSF1  +++  - 
PI3K/Akt  +++  - 
ERK  +++  ++ 
JNK  ++  +++ 
p38  +  + 
PLCɣ  +++  - 
JAK/STAT  +++  - 
c-Abl  +  +++ 
a p53: tumor suppressor protein 53; NFkB: nuclear factor kB; HSF1: heat shock transcription factor 1; 
PI3K: phosphoinositide 3-kinase; Akt: protein kinase B; ERK: extracellular signal-regulated kinases; JNK: c-
Jun N-terminal kinases; p38: p38 mitogen-activated protein kinases; PLCɣ: phospholipase Cɣ; JAK: Janus 
protein kinase; STAT: signal transducers and activators of transcription; c-Abl: c-Abl tyrosine kinase. b (-): 
minimal or no evidence of influence; (+): some evidence for the outcome; (++): much evidence that the 
pathway promotes this outcome; (+++): predominant outcome for this pathway. 
Endogenous sources
Mitochondria
Peroxisomes
Lipoxygenases
NADPH oxidase
Cytochrome P450
Antioxidant defenses
Enzymatic systems
CAT, SOD, GPx
Non-enzymatic 
systems
Glutathione
Vitamins
Exogenous sources
UV light
Ionizing radiation
Chemotherapeutics
Environmental toxins
Inflammatory cytokines
More
Less
ONOO
-
·RO
·NO2
·O2
·NO
·OH
O2
·RO
H2O2
·O2
-
Impaired 
physiological function
Homeostasis
Impaired 
physiological function
Decreased proliferative response
Defective host defenses
Normal growth and metabolism
Random cellular damage
Specific signaling pathways
Cell death
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Continuous work to discover oxidative stress biomarkers has been developed in order 
to understand and establish correlations between the mechanisms behind this process, 
and the possible prevention of its effects (12). 
 
2.1. Molecular damage 
 
2.1.1. Lipid peroxidation 
 
Briefly, lipid peroxidation is a self-propagation chain reaction, representing one of 
the most harmful toxic phenomena to cellular viability. The polyunsaturated fatty acids 
(PUFA) located at the cell’s membrane are highly affected by this ROS-mediated process. 
Glycolipids, phospholipids and cholesterol are also well-known targets. The process is 
initiated when a hydrogen atom is abstracted from a methylene group, resulting on the 
formation of a carbon radical, which then suffers a rearrangement into a conjugated diene, 
capable of reacting with oxygen and originating a lipid peroxyl radical (ROO·). The chain 
reaction is propagated when these radicals further abstract hydrogen atoms from other 
lipids, to form lipid hydroperoxides (ROOH). Also peroxyl radicals can undergo a 
cyclisation reaction forming endoperoxides, precursors of malondialdehyde, an important 
marker of oxidative stress able to impair several physiological mechanisms and to react 
with DNA and proteins (13). Another toxic secondary lipid peroxidation product is 4-
hydroxy-2-nonenal (14).   
Lipid peroxidation-derived aldehydes can easily diffuse across membranes and 
covalent bind to proteins in cytoplasm and nucleus. The continuity of this process leads to 
the loss of membranes’ integrity and to possible severe cellular and tecidual injuries (14). 
 
2.1.2. Proteins oxidation 
 
Proteins are also a main target of oxidative stress and due to their ubiquitous 
location in cells the result of this process can be highly toxic. Besides ROS/RNS, they can 
also be damaged by sugars and aldehydes. Diverse intracellular pathways may be 
affected, since the modification of proteins can directly alter the expression of genes via 
modulation of transcription factors. Intrinsically related to proteins oxidation are the 
mechanisms of protein repair and elimination, with important roles on the pathophysiology 
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of cardiovascular and immune system diseases, cancer and neurodegenerative diseases 
such as Alzheimer’s and Parkinson’s (15).  
 The modifications suffered by proteins can be generally summarized in three 
categories (16): i) oxidation of the protein backbone, resulting in protein fragmentation 
and/or intra or inter-molecular cross-links (Table 2); ii) oxidation of the amino acid side 
chains, including cysteine and methionine residues (reversible modifications), aromatic 
amino acid residues and peroxynitrite reactions with methionine, cysteine, tyrosine and 
tryptophan residues; iii) generation of protein carbonyl derivatives that can result from the 
oxidative cleavage by either α-amidation or oxidation of glutamyl side chains, directly from 
the oxidation of sensitive amino acid side chains, by the reaction with aldehydes produced 
by lipid peroxidation, like 4-hydroxy-2-nonenal and malondialdehyde, and protein glycation 
(advanced glycation end products) (17).  
Again, the final outcome depends on the amount and kind of the oxidants and on 
the number of alterations induced (18). The result can simply be not significant to alter the 
native form of the protein or lead to an unfolded protein structure, associated with the loss 
of functionality and activity (Table 2).        
 
Table 2. Protein damage according to the modifications induced by oxidative stress (adapted from (18)). 
Modifications  Properties 
   
Native, unmodified  Active 
Correctly folded form 
Oxidized, but bot cross-linked  Progressive oxidative modification 
Increased unfolding 
Increasing loss of activity 
Heavily oxidized and cross-linked  Insoluble and undegradable material 
Mainly located in the lysossomal system 
Inhibitory effects on the proteasome 
Showing cytotoxic effects 
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2.1.3. DNA damage 
 
The permanent damage of the genetic material is known to trigger mutagenesis 
and carcinogenesis, being implicated several diseases (19). 
DNA damage by ROS/RNS is caused by direct interaction with the radical 
species, either by addition to bases or abstractions of hydrogen atoms from the sugar 
moieties (20). In DNA bases’ damage the ·OH radical is added to the double bond of 
pyrimidines and purines, especially in high electron density areas, due to its electrophilic 
nature, resulting in the formation of adducts (Fig. 2). They can also propagate the 
oxidative process with formation of a large variety of by-products.  
 
Figure 2. Reaction between the hydroxyl radical and the pyrimidine base cytosine (adapted from (20)). 
 
As for the sugar moieties damage, a hydrogen atom is abstracted from the 
carbon atoms with formation of carbon-centered radicals, leading to further reactions. As 
result, the release of free modified sugars can be observed and when not released they 
can be present as end groups of broken DNA strands, both being on the basis of the DNA 
strand breakage phenomenon. Moreover, unaltered sugar moieties, base-free sites, can 
be formed by the elimination of modified DNA bases because of the weakness of the 
glycosidic bonds. The addition of a DNA base’s radical to an aromatic amino acid of 
proteins or its combination with an amino acid radical, seem to be the mechanisms behind 
covalent DNA-protein cross-links (20). 
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One of the most studied biomarkers for DNA oxidative damage is the guanine 
residue-induced lesion by hydroxyl radical, 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-
oxodG), which is pro-mutagenic and relatively easy to form (Fig. 3) (21).  
 
Figure 3. Reactions leading to the formation of the DNA stress biomarkers 8-oxodG and its tautomer 7-
hydro-8-hydroxy-2’-deoxyguanosine (8-OHdG). 2’-Deoxyguanosine reacts with hydroxyl radical resulting in the 
formation of three possible adducts. C8-OH-adduct radical suffers reduction into 7-hydro-8-hydroxy-2’-
deoxyguanosine, or into 8-oxodG (favored by keto-enolic tautomerism) and 8-OHdG by oxidation. 
 
There has been a huge development in discovering new molecules and proper 
techniques to correctly identify and quantify them (22). 
+ OH∙
∙
C4-OH-adduct radical
C5-OH-adduct radical
∙
∙
C8-OH-adduct radical
dR = 2’-deoxyribose
+e-, +H+
7-hydro-8-hydroxy-2’-deoxyguanosine
-e-, -H+
8-oxodG 8-OHdG
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2.1.4. Mitochondrial oxidative damage 
 
Mitochondria represent one of the most important sources of ROS and, at the 
same time, can suffer its damage (23). In the processes to produce ATP through oxidative 
phosphorylation, electrons are passed in the inner mitochondrial membrane along a series 
of complexes, known as electron transport chain, to end up reducing oxygen into water 
(Fig. 4). During this process, single electrons escape from redox centers of the transport 
chain, O2·- being formed by a single-electron reduction of molecular oxygen. Among the 
several complexes, complex I seems to be the main responsible for this phenomenon, 
being stimulated by succinate, a substrate of complex II, suggesting that an inverse 
electron flow is involved (Fig. 4).  
 
Figure 4. Mitochondrial ROS formation. Complex I is stimulated by succinate, a substrate of Complex II, 
suggesting that an inverse electron flow is involved (adapted from (23)).  
  
Other ROS species like H2O2 can then be originated spontaneously from 
superoxide radical, or catalyzed by superoxide dismutase (SOD) (24). Moreover, in the 
presence of ferrous iron (Fe2+), H2O2 can precede the formation of hydroxyl radicals via 
Fenton reaction. Additionally, monoamine oxidase, present in the outer mitochondrial 
membrane, is an important source of ROS, by oxidative deamination of primary aromatic 
amines, tertiary cyclic amines and long-chain diamines. 
 Once mitochondrial antioxidant systems are overwhelmed by ROS, the oxidative 
damage can occur. Besides de molecular damages described before, mitochondria are 
affected in some specific targets. Mitochondrial DNA is extremely sensitive, since it is 
proximate to the electron transport chain and lacks protection from histones. Its damage 
can affect cellular vital processes like ATP production and cause disturbance of the 
mitochondrial membrane potential. As examples of other complex toxic mechanisms 
Succinate
NADH
I III IV
II
O2 + 4H
+ 2H2O
4e-
O2
.-
O2
.-
O2
.-
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triggered by ROS exposure are the inactivation of aconitases (iron-sulfur proteins), with 
the consequent release of iron, and the loss of calcium homeostasis (23).   
 
2.2. Antioxidant mechanisms 
 
 As discussed above, cells have developed defensive mechanisms against 
oxidative stress. Attending to their origin they can be classified as endogenous or 
exogenous and can actuate either in a preventive manner, as radical scavengers or even 
in reparation processes (25). Preventive antioxidants reduce de radical species formation, 
act by metal ions chelation and can mediate in dismutation reactions. As for radical 
scavengers, they play a pivotal role stopping the lipid peroxidation chain reactions due to 
the formation of more chemical stable molecules. The last group can repair oxidative 
damage induced by ROS on proteins, DNA and cell’s membrane. 
 One of the must studied non-enzymatic endogenous antioxidants is glutathione 
(Fig. 5), ubiquitously present in the nucleus, endoplasmic reticulum and mitochondria of all 
cells. It is physiologically important for the maintenance of the essential thiol status of 
proteins, detoxification mechanisms, provides a reservoir for cysteine, modulates the 
activity of neurotransmitter receptors and is involved in diverse cellular processes, like 
DNA synthesis and immune functions (26). Its synthesis occurs by two sequential ATP-
dependent reactions catalyzed by ɣ-glutamylcysteine synthetase (rate-limiting enzyme) 
and glutathione synthetase (26).  
 
Figure 5. Structure of the tripeptide ɣ-L-glutamyl-L-cysteinyl-glycine or glutathione.   
  
As antioxidant, it is a primary line of defense and is found at a reduced state (GSH) 
and oxidized state (GSSG), also associated with proteins acting as coenzyme for the 
denominated glutathione-dependent enzymes (Fig. 6).  
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Figure 6. Glutathione redox-cycle and antioxidant activity. 
 
 Ascorbic acid, α-tocopherol and β-carotene are also examples of other non-
enzymatic antioxidants (27). 
 As for enzymatic endogenous mechanisms, SOD, catalase (CAT) and GSH-
dependent enzymes are considered the most important antioxidants. Their main purpose 
is to act against ROS.  
 Superoxide dismutase enzymes are classified according to their constitutive metal 
ion: Cu/Zn-SOD, Mn-SOD and Fe-SOD. They catalyze superoxide radical dismutase into 
hydrogen peroxide and oxygen: 
 
 Catalase enzyme can either catalyze hydrogen peroxide or oxidize hydrogen 
donors with hydrogen peroxide consumption:     
 
 
 Glutathione peroxidases (GPx) are a family of selenoproteins able to reduce 
hydroperoxides to the corresponding hydroxyl compounds:  
 
 
 They have particular notoriety in the gastrointestinal tract as defense against diet-
derived hydroperoxides or xenobiotic metabolites. During this process selenium is 
oxidized and a seleno-dissulfide is formed, which is then cleaved by a second GSH 
molecule yielding the reduced GPx (28). 
Substrate
Oxydized
substrate
NADH
NADP+
NADPH ROH
H2O
NAD+
Glutathione reductase
GSSG
GSH
Glutathione peroxidase
H2O2
ROOH
2O2
·-+ 2H+
SOD
H2O2 + O2
2H2O2 
CAT
2H2O + O2
AH2 + H2O2 
CAT
A + 2H2O  
2GSH + H2O2 
GPx
GSSG + H2O  
2GSH + ROOH 
GPx
GSSG + H2O + ROH  
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 Glutathione S-transferases (GST) are known by their ability to detoxify xenobiotics 
and to inactivate endogenous reactive molecules. They constitute a second line of 
defense against oxidative stress since they catalyze the conjugation of GSH with oxidation 
end-products (28). 
 Despite the de novo synthesis, GSH levels can be maintained through a reaction 
catalyzed by glutathione reductase (GR): 
 
 
 The role of phenolic compounds, as representatives of exogenous antioxidants, 
will be discussed forward. 
 
2.3. Antioxidant activity assessment 
 
 Distinct methods and experimental models have been developed in order to 
assess the antioxidant activity of a given compound/extract (29). The more classic ones 
consisted on the measurement and presentation of the results as total antioxidant 
capacity or total antioxidant activity. The reductive and radical scavenging activities can 
be classified in three main groups: i) ability to reduce metal ions, including the ferric ion 
reducing antioxidant power (FRAP), ii) ability to reduce organic radicals, 2,2-diphenyl-1-
picrylhydrazyl (DPPH·) and 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid 
(ABTS·+) radicals being the most commonly used, and iii) peroxyl radical reduction ability 
assays, like the oxygen radical absorbance capacity (ORAC) and total radical trapping 
antioxidant parameter (TRAP).  
 Other parameters, such as metal ions chelating activity, inhibition of free radical 
generating enzymes and activation of internal antioxidant enzymes like CAT, SOD and 
GSH-dependent enzymes are also frequently applied.   
 Nowadays, determinations based only on a chemical approach are used as 
screening tools for cell based systems, since they do not take into consideration 
bioavailability and metabolic variables (30). 
  
 
 
GSSG + NADPH + H+
GR
2GSH + NADP+
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3. Phenolic Compounds 
 
 Concerning to the most studied chemical families of natural bioactive compounds, 
polyphenols are certainly the best example. With ubiquitous distribution and comprising 
molecules from low molecular weight to more than 30000 Da, they are particularly known 
for their antioxidant (31), anti-inflammatory (32) and antimicrobial (33) properties. These 
secondary metabolites are biosynthesized via shikimate and acetate pathways. They can 
present simple structures like the phenolic acids, or complex polymeric ones characteristic 
of tannins. Additionally, in heterosides’ structure the aglycone can be linked to sugar 
residues either by their hydroxyl groups or by carbon atoms of the main skeleton. 
Although glucose is the most common sugar, others like rhamnose, galactose, xylose and 
glucuronic acid are frequently observed (34). 
 
3.1. Flavonoids and hydroxycinnamic acids 
 
Flavonoids are phenolic compounds with a common structure known as 2-phenil-
benzopirane (C6-C3-C6), consisting in two aromatic rings linked by three carbons, usually 
forming an oxygenated heterocycle (Fig. 7) (34). The A ring usually comes from a 
resorcinol or phloroglucinol via acetate pathway, while the B ring is biosynthesized by the 
shikimate pathway (34). These compounds can be sub-classified according to different 
substitutions in the main structure (Fig. 7).   
Introduction 
 
34 
 
 
Figure 7. Common structure of flavonoids (2-phenyl-benzopirane), and main sub-classes. 
 
Among the phelylpropanoid derivatives (C6-C3) the hydroxycinnamic acids are 
considered to be the most important compounds  (Fig. 8) (35). 
 
 
Figure 8. Basic structure of hydroxycinnamic derivatives. 
 
3.2. Phenolic compounds as antioxidants 
 
Behind the antioxidant properties of phenolics underlies a conjugation of a vast 
number of mechanisms. Their characteristic hydroxyl groups easily donate hydrogen 
atoms to radical species, stopping the chain reactions due to the formation of a non-
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propagating radical. Another mechanism is by metal ions’ chelation, despite that 
sometimes it leads to pro-oxidant activity (36).  
Recent studies show that besides this more classic mechanisms, phenolic 
compounds can interact with biological systems by modulation of signal transduction 
pathways, or even interaction with cell receptors. Moreover, phenolic compounds seem to 
be able of endogenous cell antioxidants induction, like sulfotransferases, epoxide 
hydrolases and GSH and GSH-related enzymes, through the modulation of antioxidant 
responsive elements located in the promoters of diverse genes (28). 
Focusing on flavonoids, their antioxidant activity is intrinsically correlated to their 
chemical structure. Generally, aglycones are more potent antioxidants than their 
corresponding glycosides. The number and configuration of hydroxyl groups influences 
the antioxidant activity, B-ring configuration as 3’,4’-cathecol structure seeming to be the 
most determinant (Fig. 9) (37).  
 
 
Figure 9. Structure-activity relationship of flavonoids.  
 
A greater stability of the flavonoid radical is observed when there are present a 
carbonyl group at position 4 and a 2-3 double bound between A and B rings, due to the 
resonance effect of the aromatic nucleus (Fig. 9) (37). Furthermore, differences in the 
hydrophobicity and molecular planarity due to substitutions either by hydroxyl or methoxyl 
groups have been noticed. When a methoxyl group is present at the B-ring, the 
scavenging activity is diminished by the steric obstruction caused to the 3’,4’-cathecol 
structure, when compared to the ones with hydroxyl substitutions (37). 
Some of the same features can be applied to hydroxycinnamic derivatives. The 
highest antioxidant activity is related with the presence of more hydroxyl groups, 
especially on ortho positions, but contrary to flavonoids it is enhanced by methoxyl 
substitutions on the catechol group (38). The propenoic side chain in hydroxycinnamic 
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derivatives, instead of the carboxylic group of benzoic acid derivatives, provides additional 
stability by resonance on the phenoxyl radical, thus highest activity (38). 
  
4. The genus Mentha 
 
 Mentha genus is one of the most important and studied within Lamiaceae 
(Labiatae) family, in the Order Lamiales. Its species are commonly known as mints due to 
their characteristic menthol flavor (39). Mints have an important commercial value, since 
they are used in industry, medicine and agriculture. In the Northwest of the Iberian 
Peninsula they have a particular application in gastronomy as aromatic herbs, being also 
consumed as herbal teas (40, 41). 
 The systematics of this genus is not consensual. Regarding the number of species 
included, it varies depending on the type of study, being rather morphological, cytological, 
anatomical, phytochemical or genetic (42). The complex classification is based on the 
ease of hybridization favored by gynodioecy, that despite the majority of infertile 
specimens created, has a strong capacity of dissemination by vegetative propagation in 
Nature and crop species (43). The last proposed classification refers to the presence of 18 
species and 11 hybrids, distributed by four sections: Mentha, Eriodontes, Tubulosae and 
Pulegium (44). 
 Concerning mints as sources of bioactive compounds, they provide a distinct 
number of molecules like alkaloids, flavonoids, phenolic acids and terpenoids (45). The 
most part of the scientific studies approaching the pharmacological and toxicological 
potential of these species focus on their essential oils. Different activities, such as 
insecticidal (46), antimicrobial (47), anti-inflammatory (48), analgesic (49), and antioxidant 
(50), are well established. Also, essential oils are highly toxic and the ingestion of large 
amounts results on acute toxicity with allergic reactions and hepatic injuries (51). 
 One traditional way for mints classification is based on the analysis of the chemical 
composition of the essential oils, identifying which is the major monoterpenoid present 
and respective metabolic pathway. There by, the species can be categorized in three 
groups: one with major expression of the menthol pathway, other with major expression of 
the carbon pathway, and the last with major expressing of the linalool pathway (Table 3). 
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Table 3.  Mints classification according to the major monoterpenoid present in the essential oil and its 
metabolic pathway (adapted from (42)). 
Menthol pathway  Carvon pathway  Linalool pathway 
     
Mentha aquatica L.  Mentha spicata L.  Mentha x piperita (L.) Huds var. 
lavanduliora ined. Mentha arvenses L.  Mentha x villosa 
Huds. 
 
Mentha longifólia L.  Mentha suaveolens 
Rhr. 
 Mentha x aquatica var. citrata 
(Ehrh.) Frensen. 
Mentha pulegium L.    
Mentha x piperita L.     
Mentha x verticillata L.     
 
 Mentha pulegium L. has particular interest in the Mediterranean and Portuguese 
cultures (Fig. 10). It is an herbaceous species with height ranging between 20 and 40 cm, 
strongly aromatic and little elliptic oblongated leaves (8 to 30 mm length); it has 
characteristic spherical verticillated inflorescences, ciliate calyx-teeth and a lilac corolla 
measuring around 5 cm; it can be easily found in Europe and Western Asia, with large 
distribution in continental Portugal and Azores; its habitat consists in high humid areas, 
mostly near water courses (52). 
 
Figure 10. Mentha pulegium Linnaeus. 
  
In phytotherapy, the flowered aerial parts and the essential oil are used to treat 
and prevent diverse gastrointestinal disorders like the lack of appetite, intestinal cramps, 
low intestinal motility, flatulence and dyspepsia, and to alleviate cold and flu-related 
symptoms. External application is due to their antiseptic and healing properties. In 
Portugal, popularly known as “poejo”, it is used in gastronomy as an aromatic herb in the 
regions of Trás-os-Montes and Alentejo, consumed as an alcoholic beverage (“licôr de 
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poejo”) and herbal tea, being also used as parasites and insects’ repellent at livestock 
farms (53). 
 M. pulegium essential oil, or pennyroyal oil, has emmenagogue and abortifacient 
properties. It is used by women to induce menstruation and abortion (54). The ingestion of 
high doses can lead to acute intoxication and death, owing to the presence of pulegone 
and its bioactive metabolite menthofuran, both strong hepatotoxic agents (55). 
 
4.1. Mentha pulegium L. chemical profile 
 
4.1.1. Terpenoids 
 
 The vast class of terpenoids includes more than 40.000 different known 
structures. Synthesized by plants, they have a huge impact in their life cycle as primary 
and secondary metabolites. Among other biological functions, they play important roles as 
membrane’s constituents, hormones, photosynthetic pigments, in communication and as 
natural mechanisms of defense. Widely found in medicinal plants’ essential oils, they are 
of great importance to the pharmaceutical and food processing industries (56). 
Terpenoids are biosynthesized by mevalonate (cytosolic) and non-mevalonate 
(plastidic) pathways, both converging on the isoprene formation, the basic functional unit. 
The addition of isopentenyl pyrophosphate units to its isomer dimethylallyl pyrophosphate 
results in new precursors of other complex terpenoids, via prenyltranferases. Based on 
the number of isoprene units (5 carbons) present on the structure, terpenoids can be sub-
classified into several groups (Fig. 11).   
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Figure 11. Terpenoids biosynthesis. From the condensation of isopentenyl pyrophosphate (IPP) and 
dimethylallyl pyrophosphate (DMAPP), higher terpenoids precursors are formed. Geranyl pyrophosphate 
(GPP) is the monoterpenoids’ precursor, farnesyl pyrophosphate (FPP) is the sesquiterpenoids’ precursor and 
geranylgeranyl pyrophosphate (GGPP) is the diterpenoids’ precursor. Squalene, being the precursor of 
triterpenoids, results from de condensation of two FPP units. Two GGPP units condense to form 
tetraterpenoids (adapted from (56)). 
 
 As previously described, mints can also be classified by the major monoterpenoids 
present in their essential oils. In the essential oil of M. pulegium pulegone, menthone, 
piperitenone and piperitone (Fig. 12) are the main monoterpenoids, biosynthesized by the 
menthol pathway. According to the oxygenated monoterpenoid present, this species can 
also be classified in 3 distinct chemotypes: pulegone type, piperitone/piperitenone type 
and isomenthone/neo-isomenthol type (44). 
 
Figure 12. Major monoterpenoids present in the essential oil of M. pulegium. 
 
 Other classes, such as hydrocarbonated monoterpenes (limonene, α-pinene and 
camphene), sesquiterpenes (β-borbene), oxygenated sesquiterpenes (palustrol and α-
cadinol), oxygenated diterpenes (epimanoyl oxide), among others, can also be found in 
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the aerial parts of the plant (57). Recently, new terpenoids have been identified in the 
leaves, but no significant antioxidant or antimicrobial activity was described (58). As 
essential oils are obtained from natural sources, their chemical composition can vary 
according to the physical-chemistry characteristics of soil, climate and maturation stage of 
the species (59). 
 
4.1.2. Phenolic compounds 
 
As for the phenolic profile of M. pulegium, a lot of work has to be done. A few 
number of compounds has been identified and the literature on this subject is scarce and 
lacks consistency. Most of the studies available are directed to the total quantification of 
phenolic compounds and not to their structural characterization, leaves being the most 
studied material. The presence of flavonoids and phenolic acids has already been 
reported for this species’ extracts. 
Phenolic acids, such as caffeic, vanillic, ferulic, rosmarinic and lithospermic, and the 
flavonoids luteolin, apigenin, naringenin, (+)-catechin and diosmetin 7-O-rutinoside are 
some examples of the compounds already identified (Fig. 13) (60-65). Also jaceosidin, 
pectolinarigenin and pedalitin were found in M. pulegium leaves’ alcoholic extracts (66).  
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Figure 13. Chemical structures of some phenolic compounds identified in M. pulegium extracts. 
 
4.2. Pharmacologic and toxic activities 
 
4.2.1. Antioxidant activity 
 
 As above mentioned, there are available a variety of in vitro assays to assess the 
antioxidant activity of extracts, sometimes making hard to correlate the results obtained. 
Here will be presented some examples of works concerning diverse extracts of M. 
pulegium. 
 The potential to scavenge DPPH· radical was evaluated for the methanolic extracts 
of flowered aerial parts of mint species (67). When compared to the other mints, M. 
pulegium showed a lower ability; nevertheless, 76% of scavenging activity was found at 
0.4 mg/mL, a very promising result. Neither the chemical profile of each extract nor the 
phenolic quantification were determined, rendering impossible an attempt to link the 
activities with the compounds present.  
Ferulic acid Caffeic acid
Rosmarinic acid
Lithospermic acid
Apigenin
Luteolin 7-O-Glucoside
Naringenin (+)-Catechin
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 In another work, with the methanolic extract of M. pulegium at flowering stage, it 
was confirmed a significant scavenging ability against DPPH· and ABTS·+ radicals and a 
marked capacity to chelate metal ions (68). The hexane extract demonstrated a poor 
potential in all in vitro assays and the lowest phenolic content.  
 The antioxidant potential of the essential oil, assessed by DPPH· assay, was lower 
than that of the methanolic extract (69). 
 In a more complete analysis, the temperature of extraction seemed to be an 
important variable to obtain better antiradical activities (57). Polar extracts were richer in 
phenolic compounds than the essential oil and generally more active. Additionally, the hot 
water extract presented higher phenolic content and more marked activities than the cold 
water extract (57).  
Traditionally herbal teas are prepared with hot water. Hence an efficient extraction 
of polyphenols can be achieved, with great benefits for consumers. 
 The antioxidant activity was also assayed in vivo (70). Albino Wistar rats were 
treated for seven days by oral administration of an ethanolic extract from M. pulegium 
leaves. The toxicity was than induced with CCl4. At 600 mg/Kg the extract was able to 
protect against the toxicant. The monitored biomarkers, glutathione, SOD, CAT and 
peroxidase, were proximal to control’s basal values, and the ethanolic extract was not 
toxic up to 2000 mg/Kg. However, the authors did not proceed with a histologic analyses 
that could sustain a relation between blood concentrations and actual tecidual damage.      
 
4.2.2. Antigenotoxic and antimutagenic activities 
 
 The somatic mutation and recombination test (SMART) was applied to evaluate 
the genotoxicity of M. pulegium aqueous extract (71). The results showed that it was not 
genotoxic: in fact, it was demutagenic when assayed in co-exposition with hydrogen 
peroxide, thus preventing oxidative stress.  
 The protective effect against CCl4-induced toxicity was also studied in human 
peripheral blood lymphocytes (72). Through the sister chromatid exchange (SCE) test, the 
methanolic extract demonstrated a very significant anti-genotoxic activity, reversing the 
CCl4 induced damage. Additionally, the activities of antioxidant related enzymes (SOD 
and GPx) and GSH levels were evaluated and the oxidative stress biomarker 
malondialdehyde was quantified. As expected, when cells were treated with CCl4 alone 
the enzymatic activity decreased and the levels of malondialdehyde significantly 
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increased. On the other hand, when co-exposed to both methanolic extract and CCl4, an 
increase of enzymatic activities and a decrease of malondialdehyde levels was observed, 
suggesting an antioxidant protective role mediated by the extract.       
 In another work the antimutagenic activity of methanolic and hexane extracts was 
evaluated against Fenton reagent (68). The DNA nicking assay technique was applied, 
and it was observed a significant reduction in the formation of plasmid pBR 322 nicked 
DNA, and increased native form. Furthermore the observed protective effect was more 
prominent for the methanolic extract than for the hexane extract. Phenolic compounds 
share more polarity similarities with methanol, and effectively the methanolic extract 
presented a higher phenolic content and more effective radical scavenging and metal 
chelation activities. It was suggested that these mechanisms were behind the protection 
against the lethal effects of oxidative stress by the generated hydroxyl radical. 
 
4.2.3. Cytotoxicity  
 
 Diverse cell lines have already been subjected to M. pulegium extracts exposure. 
According to the results obtained in the MTT viability assay, the essential oil was more 
toxic for the cell lines Vero (green African monkey kidney), HeLa (human malignant cervix 
carcinoma) and HEp-2 (human laryngeal carcinoma) than the methanolic extract (73). In 
this study the lowest most sensitive cells were those from Vero (extract LC50 = 51.2 
µg/mL) and HeLa (essential oil LC50 = 30.6 µg/mL) lines.    
 In another study the cell lines HeLa, SK-OV-3 (human ovarian adenocarcinoma) 
and A549 (human lung carcinoma) were also exposed to both methanolic extract and 
essential oil of flowered parts (74). By using different viability assays, clonogenic and 
neutral red vital dye, no cytotoxic effects were observed when exposed to the extract. SK-
OV-3 and A549 cells were the most sensitive to essential oil exposure, LC50 values of 
14.4 and 18.76 µg/mL being found, respectively.        
 The methanolic extract also did not lead to significant viability decrease of Caco-2 
(human colon carcinoma), HepG2 (human hepatoblastoma) and MCF7 (human breast 
cancer) cells, as observed with crystal violet dye (75). 
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4.2.4. Antimicrobial and insecticide activities  
 
 As discussed before, M. pulegium is also traditionally used as an insect repellent 
at live stocks farms. The essential oil is particularly active against some species, such as 
Mayetiola destructor, Dermatophgoides farina, Malus domestica and Drosophila 
melanogaster (76).  Other extracts, like hexane and methanolic, are also active but less 
effective, which is explained by the lipophilic nature of the essential oil and its strong 
impairment to insects’ metabolism and physiologic and behavior regulation. Moreover 
oxygenated monoterpenoids, like pulegone (Fig. 14), are more active than the non-
oxygenated ones. Monoterpenoids are toxic to insects central nervous system and 
metabolized by cytochrome p450, being also strong inhibitors of acetylcholinesterase 
(AChE) and octopamine receptors (77).    
 The increasing microbial resistance to antibiotics makes necessary the pursuit of 
new active molecules. In a study focusing M. pulegium essential oil chemical 
characterization, as well as its antibacterial potential, it was reported, as expected, that 
Gram-negative bacteria were less sensitive than Gram-positive bacteria, with the 
exceptions of Vibrio cholera and Listeria monocytogenes (78). The best activities were 
obtained against Staphylococcus aureus and Staphylococcus epidermidis. The results 
were attributed mainly to the presence of piperitone and piperitenone (Fig. 14).   
 Different strains were also tested to compare the antibacterial potential between 
the essential oil and different extracts. From the results obtained it could be observed that 
all microorganisms presented extraordinary more sensibility to the essential oil than to 
aqueous and ethanolic extracts exposure. Behind such activity was the presence of 
menthone, pulegone and neomenthol, compounds able to cause cellular membrane 
damages (57).  
   The essential oil obtained from M. pulegium leaves was very effective against 
Malassezia furfur fungus, with a 0.5 cm inhibition halo radius at 2 mg/mL (79). 
 
4.2.5. Other activities 
 
 The ability to inhibit AChE was determined for M. pulegium essential oil, ethanolic 
and aqueous extracts, along with other four aromatic herbs (80). For all the species, the 
best activities were obtained with the essential oils, followed by ethanol extracts and 
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aqueous extracts. Specifically for M. pulegium the IC50 values were 324 µg/mL, 534 µg/mL 
and 1581 µg/mL, respectively, thus showing a moderate anticholinesterase activity.  
 Aiming to investigate potential central nervous system activities, the protective 
effect of the methanolic extract was tested against hydrogen peroxide-induced toxicity in 
PC12 cells (81). The capacity to inhibit monoamine oxidase A (MAO-A), AChE and the 
binding affinity to ɣ-aminobutyric acid A receptor (GABAA) were also evaluated. When co-
exposed to H2O2 and methanolic extract (1000 µg/mL) a statistically significant protection 
effect was observed. As for MAO-A inhibition, a dose-dependent activity was noticed 
(IC50= 59 µg/mL), but no relevant results were obtained for the ability to bind to GABAA. 
Unlike the results obtained with the previous, the methanolic extract did not inhibit AChE. 
Among the five mints analyzed M. pulegium showed some of the less relevant 
neuroprotective and neurochemical activities.   
 Phenolic compounds are known for their strong metal ion chelating property. When 
in the intestinal lumen, they can easily complex with iron, resulting in lower absorption. A 
study was developed to measure the effects on iron absorption resulting from the 
ingestion of polyphenol-rich beverages, based on an extrinsic tag radio-Fe technique 
(55Fe, 59Fe) to evaluate erythrocyte incorporation (82). M. pulegium infusion was able to 
reduce iron absorption by 73% when compared to water control ingestion, leading the 
authors to admonish the possible risk of its consumption by anemic patients.  
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 The main objectives of this dissertation were: 
 
 To establish the phenolic profile of M. pulegium infusion; 
 
 To evaluate the response of Caco-2 and AGS cell lines to the infusion exposure;  
 
 To verify the protective potential against tert-butylhydroperoxide-induced toxicity; 
 
 To understand the mechanisms behind the antioxidant activity; 
 
 To check the presence of intracellular phenolic compounds; 
 
 To co-relate the chemical profile with the observed biological activities. 
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1. Materials and methods 
 
1.1. Standards and reagents 
 
 Sodium pyruvate, 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), β-
nicotinamide adenine dinucleotide reduced form (NADH), tert-butylhydroperoxide (t-BHP), 
sodium nitroprusside dehydrate (SNP), phenazine methosulfate (PMS), nitroblue 
tetrazolium chloride (NBT), N-(1-naphthyl)ethylenediamine dihydrochloride, sulfanilamide, 
amphotericin B (250 µg/mL), transferrin (4 mg/mL), non-essential amino acids, methanol, 
formic acid, sodium hydroxide, acetonitrile, formaldehyde, perchloric acid, dimethyl 
sulfoxide (DMSO), 4’,6-diamidino-2-phenylindole dihydrochloride (DAPI), 2-aminoethyl 
diphenylborinate (DPBA), GSH, GSSG, glutathione reductase (EC 1.6.4.2), caffeic, 
chlorogenic and rosmarinic acids  were purchased from Sigma-Aldrich (St. Louis, MO, 
USA). Ferulic acid, luteolin 7-O-glucoside and apigenin 7-O-glucoside was from 
Extrasynthese (Genay, France) and 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) from Alfa 
Aesar (Karlsruhe, Germany). Dulbecco’s Modified Eagle Medium (DMEM), Dulbecco’s 
phosphate buffered saline (DPBS), Hank's Balanced Salt Solution (HBSS), fetal bovine 
serum (FBS), Pen-Strep solution (Penicillin 5000 units/mL and Streptomycin 5000 mg/mL) 
and trypsin-EDTA were purchased from Gibco (Invitrogen, Paisley, UK). Water was 
deionized using a Milli-Q water purification system (Millipore, Bedford, MA, USA). Human 
epithelial colorectal adenocarcinoma (Caco-2) and Human epithelial gastric 
adenocarcinoma (AGS) cell lines were acquired from American Type Culture Collection 
(ATCC). 
 
1.2. Samples and extract preparation 
 
Specimens were kindly collected and provided by Direção Regional de Agricultura 
entre Douro e Minho (DRAEM). The samples were dried at 30 ºC for 24 hours followed by 
powdering, and stored protected from light and humidity. In order to mimic the herbal tea 
usually prepared for human consumption, 200 mL of boiling water were added to 4.00 g of 
the powdered material and left to stand for 15 min. After filtration the obtained extract was 
frozen at -20 ºC and then lyophilized in a Labconco 4.5 Freezone apparatus (Kansas City, 
MO, USA).  
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1.3. HPLC-DAD-ESI/MSn qualitative analysis of phenolic compounds 
 
HPLC-DAD-ESI/MSn chromatographic analysis was carried out on a Kinetex 
column (5 µm, C18, 100 Å, 150 x 4.6 mm; Phenomenex, Macclesfield, UK). The mobile 
phase consisted of two solvents: water-formic acid (1%) (A) and acetonitrile-formic acid 
(1%) (B), starting with 10% B and using a gradient to obtain 30% B at 20 min. The flow 
rate was 1 mL/min and the injection volume 20 µL. Spectral data from all peaks were 
accumulated in the range of 240-400 nm and chromatograms were recorded at 330 nm. 
The analyses were carried out in an Agilent HPLC 1100 series equipped with a diode 
array detector and mass detector in series (Agilent Technologies, Waldbronn, Germany). 
The HPLC consisted of a binary pump (model G1312A), an auto sampler (model 
G1313A), a degasser (model G1322A) and a photodiode array detector (model G1315B). 
The HPLC system was controlled by ChemStation software (Agilent, v. 08.03). The mass 
detector was an ion trap spectrometer (model G2445A) equipped with an electrospray 
ionization interface and was controlled by LCMSD software (Agilent, v. 4.1). The ionization 
conditions were adjusted at 350 °C and 4 kV for capillary temperature and voltage, 
respectively. The nebulizer pressure and flow rate of nitrogen were 65.0 psi and 11 L/min, 
respectively. The full scan mass covered the range from m/z 100 up to m/z 1000. 
Collision-induced fragmentation experiments were performed in the ion trap using helium 
as the collision gas, with voltage ramping cycles from 0.3 up to 2 V. Mass spectrometry 
data were acquired in the negative ionization mode. MSn was carried out in the automatic 
mode on the more abundant fragment ion in MS(n-1). 
 
1.4. HPLC-DAD quantitative analysis of phenolic compounds 
 
 HPLC-DAD conditions were the same as those described above, except for the 
Waters Spherisorb ODS2 (25.0 x 0.46 cm; 5 μm particle size) column. 20 µL of the 
lyophilized extract dissolved in water (25 mg/mL) were injected into a HPLC-DAD unit 
(Gilson), spectral data were acquired with a Gilson-DAD and processed on Unipoint 
system software (Gilson Medical Electronics, Villiers le Bel, France). Phenolic compounds 
quantification was achieved by the absorbance recorded at 320 nm and 350 nm for 
phenolic acids and flavonoids, respectively, in relation to external calibration curves (Table 
4). Since commercial standards were not available for all the compounds, caffeic acid 
glucosides, trimmers and tetramer were quantified as caffeic acid, ferulic acid glucosides 
as ferulic acid, luteolin and apigenin derivatives as luteolin 7-O-glucoside and apigenin 7-
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O-glucoside, respectively. Caffeoylquinic acids were quantified as 5-O-caffeoylquinic acid. 
Rosmarinic acid and its derivatives were quantified as rosmarinic acid.  
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Table 4. Regression equations, LOD and LOQ for phenolic compounds quantification. 
Compoundsa Regression equation  R2  Range of concentrations  
(mg/mL) 
 LODb 
(mg/mL) 
 LOQc 
(mg/mL) 
          
5-Caffquin Ac 7.2 x 108 x - 3.1 x 106  0.994  1.2 x 10-1 – 1.5 x 10-2  4.3 x 10-4  1.3 x 10-3 
Caffeic Ac  1.5 x 109 x + 7.5 x 106  0.992  1.6 x 10-1 – 8.0 x 10-3  6.4 x 10-4  1.9 x 10-3 
Ferulic Ac 1.4 x 109 x + 6.2 x 106  0.994  1.3 x 10-1 – 6.0 x 10-3  4.7 x 10-4  1.4 x 10-3 
Rosmarinic Ac 8.2 x 108 x + 6.1 x 106  0.994  2.1 x 10-1 – 1.1 x 10-2  1.3 x 10-3  1.4 x 10-3 
Lut-7-Gluc 4.6 x 108 x + 2.0 x 106  0.999  1.20 x 10-1 – 6.0 x 10-3  1.1 x 10-4  3.4 x 10-4 
Apig-7-Gluc 8.5 x 108 x - 1.5 x 106  0.997  1.4 x 10-1 – 1.7 x 10-2  4.3 x 10-4  1.3 x 10-3 
a Caffquin: caffeoylquinic; Ac: acid; Lut: luteolin; Apig: apigenin; Gluc: glucoside. 
b Limit of detection. 
c Limit of quantification. 
 
 
 
 
 
 
 
 
Experimental section 
 
53 
 
1.5. Antiradical activity 
 
1.5.1. DPPH• scavenging assay 
 
 DPPH· is a free radical able to accept an electron or hydrogen atom becoming a 
non-radical and hardly oxidizable species. 
 The scavenging activity was determined spectrophotometrically (83). The assay 
was performed in 96-well plates and a set of extracts dilutions was prepared. The reaction 
mixture consisted on 25 µL of extract (redissolved in water) and 200 µL of DPPH· 
methanolic solution (150 mM). The plates were incubated for 30 min with light absence, 
and the absorbance at 515 nm was determined with a Multiskan Ascent plate reader 
(Thermo Electron Corporation, Vantaa, Finland). Three experiments were performed in 
triplicate. 
 
1.5.2. Superoxide radical scavenging assay 
 
Antiradical activity procedure was in accordance with previously reported (83). The 
superoxide radical was generated by the NADH/PMS system, followed by reduction with 
NBT to form a formazan blue dye.  
The reaction mixture consisted of 50 µL of sample, 50 µL NADH (166 µM), 150 µL 
NBT (43 µM) and 50 µL of PMS (2.7 µM). The plate reader was set in kinetic function, and 
the absorbance was determined for 2 min after PMS addition at 562 nm. All components 
were dissolved in phosphate buffer (19 mM, pH 7.4). Three experiments were performed 
in triplicate. 
 
1.5.3. Nitric oxide scavenging assay 
 
·NO radical was generated by a SNP solution at pH 7.4 with posterior reaction with 
oxygen to produce nitrite, that was determined by Griess reagent (83). 
 
To each well were added 100 µL of sample and SNP (20 mM), followed by 60 min 
of incubation at room temperature under light exposure. Finally 100 µL of Griess reagent 
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(1% sulfanilamide and 0.1% naphthyethylenediamine in 2% H3PO4) were added and the 
absorbance of the produced chromophore after the diazotization reaction at 540 nm was 
determined with a plate reader. Three experiments were performed in triplicate. 
 
1.6. Cellular assays 
 
1.6.1. Cell culture and treatments 
 
Cells were maintained in DMEM with 10% FBS and 2% Pen-Strep in an incubator 
at 37 ºC, with 5% CO2 and controlled humidity, in 75 cm2 flasks. Additionally Caco-2 cell 
medium was supplemented with amphotericin B (1%), transferrin (0.15% µL) and non-
essential amino acids (1%).  
Once confluence was achieved, cells were washed twice with 10 mL HBSS and 3 
mL of trypsin-EDTA were added, followed by 8 min of incubation. 200 µL of the prepared 
cellular suspension (150000 cells/mL) was seeded in 96 well-plates and incubated for 3 
days before carrying out the viability assays.  
Preliminary assays were performed to determine the appropriate t-BHP 
concentration and exposure time to assess the antioxidant activity of the infusion (data not 
shown).  Cells were seeded under the same conditions as described above. After 24 h, 
the medium was completely removed and t-BHP was added to the final concentration of 
0.5 mM, with an exposure time of 6 h. MTT and lactate dehydrogenase (LDH) assays 
were then carried out to evaluate the effect of the infusion against the induced toxicity. 
 
1.6.2. MTT assay 
 
 The yellow tetrazolium salt MTT is converted to an insoluble purple formazan 
product, by mitochondrial dehydrogenases of metabolically active cells. 
Cells were incubated with different concentrations of the infusion for 24 h. After 
medium removal, 200 µL of MTT (0.5 mg/mL in DMEM) were added to each well, followed 
by 30 min of incubation. The extent of reduction to formazan was than quantified 
spectrophotometrically by measuring the absorbance at 510 nm, and compared to 
controls (84). 
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1.6.3. LDH assay 
 
LDH is a cytosolic enzyme released into the culture medium after loss of integrity 
of the cellular membrane. LDH activity can be spectrophotometrically determined at 340 
nm, by following NADH oxidation during the conversion of pyruvate to lactate (84). 
The medium was collected after 24 h of cellular exposure to the infusion. The 
reaction mixture consisted of 50 µL of sample, 200 µL NADH (0.15 mg/mL) and 25 µL 
pyruvate (0.15 mg/mL), all prepared in phosphate buffer (0.1 M, pH 7.4).  
 
1.6.4. Determination of total and oxidized glutathione 
 
Total glutathione levels were determined by the DTNB-GSSG reductase recycling 
assay, after protein precipitation with perchloric acid (0.5%), and GSSG was determined 
after sample pre-treatment with 2-vinylpyridine for 1 h at 4 ºC, with agitation (85). The 
absorbance was read at 405 nm in kinetic function for 3 minutes. The experiments were 
conducted with and without exposure to t-BHP after incubation with the infusion. Proteins 
were quantified spectrophotometrically at 595 nm with Bradford reagent, using bovine 
serum albumin as standard. 
 
1.6.5. Intracellular polyphenols’ staining and fluorescence microscopy  
 
The procedure was based on a previous work, with some modifications (86). Caco-
2 and AGS cells were seeded at 75000 cells/mL, in 24-multiwell plates, and treated with 
infusion concentrations of 0.31 and 0.16 mg/mL respectively, for 24 h. Also a negative 
control and positive controls with apigenin (25 µM) and rosmarinic acid (25 µM) were 
evaluated under the same conditions.  
Cell’s fixation procedure consisted on removing the culture medium and adding 
600 µL of the pre-warmed 3.7% formaldehyde solution, with 10 min of incubation at room 
temperature. The solution was then removed and each well was rinsed with 600 µL 
HBSS.  
Nuclear staining was achieved with 1 µg/mL DAPI (with excitation at 364 nm and 
emission at 454 nm) for 30 min, followed by 0.1% (w/v) DPBA (excitation at 490 nm, 
emission at 530 nm) staining for 1 min. Fluorescence was detected by microscopy (Nikon 
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TS100 microscope, Tokyo, Japan) and digital images were generated with a Nikon DS-Fi1 
camera and NIS-Elements D 3.2 software (Nikon Instruments INC, New York). 
 
1.7. Statistical analysis 
 
Statistical analysis was performed using Graphpad Prism 6 Software (San Diego, 
CA, USA). Quantification of phenolic compounds was achieved from three determinations 
and results are shown as the mean (± SD). The EC50 values were calculated from three 
independent assays performed in triplicate. Cellular based assays consisted of six 
independent experiments and results are presented as mean values (± SEM). Data from 
different groups was compared using one-way ANOVA Tukey’s multiple comparisons test. 
A level of statistical significance at p<0.05 was used. 
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1. HPLC-DAD-ESI/MSn qualitative analysis of phenolic compounds 
 
The HPLC-DAD-ESI/MSn analysis of the aqueous extract of M. pulegium at 330 
nm (Fig. 14) showed the presence of diverse compounds, the majority of them with an UV 
spectrum characteristic of cinnamoyl derivatives (1-3, 7, 11-13 and 15) (Table 4). 
Compounds 1 and 3 exhibited the deprotonated molecular ion at m/z 353 (caffeoyl 
quinic acid) but different MS fragmentations, corresponding to 3-caffeoylquinic acid and 4-
caffeoylquinic acid, respectively (Table 5), according to (87). 
Compound 2, with [M-H]-ion at m/z 311 and MS fragmentation showing the loss of 132 
amu (pentosyl moiety) originating the ion at m/z 179 ([caffeic acid-H]-), can possibly be 
labelled as caffeoylpentoside. The MS2 of compound 7 presented losses of -162 (hexosyl 
moiety), of -(162+18), corresponding to an interglycosidic linkage, and of -(162+132) 
(hexopentosyl moiety) over a caffeic acid (179, [caffeic acid-H]-) (Table 4). Moreover, its 
MS3[(M-H) →(M-H-162)]- was similar to the MS2 of compound 2; as so, compound 7 
should be a derivative of compound 2 with an additional hexose over the pentose, being 
here characterized as a caffeoyl hexosylpentoside. Compound 12 exhibited an UV 
spectrum similar to that of 7. Both the deprotonated molecular ion and the fragmentation 
pattern of compound 12 differed from those of compound 7 in 14 amu: since [feruloyl acid-
H]- (193 amu) was observed instead of the ion at m/z 179 [caffeic acid-H]-, compound 12 
was identified as feruloyl hexosylpentoside.  
With a similar UV spectrum (Table 5) and a deprotonated molecular ion at m/z 359, 
compound 11 presented in its MS2 fragmentation losses of 3,4-dihydroxyphenyllactic acid 
(danshensu (DSS),-198 amu), caffeic acid (-180 amu) and caffeic acid-18 (-162 amu), 
with formation of ions at m/z 161, 179 and 197, respectively; according to (88) these are 
characteristics of dimers, trimmers and tetramers of caffeic acid. This fragmentation 
pattern is in agreement with the one reported for rosmarinic acid (89) and the co-elution of 
the extract with a standard allowed the characterization of compound 11 as rosmarinic 
acid. 
Compound 15 also displayed a similar UV spectrum (Table 5) and its MS 
fragmentation showed a loss of 176 amu (feruloyl moiety), with formation of the ion at m/z 
359. As the fragmentation (MS3[535→359]-) observed matched with the one of rosmarinic 
acid, compound 15  was tentatively identified as a feruloyl rosmarinic acid derivative.  
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Figure 14. HPLC-DAD-ESI/MSn chromatogram (330 nm) of M. pulegium infusion. Ac: not identified cinnamoyl derivatives. Identity of compounds as in Table 5. 
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Table 5. Rt, UV and MS: M-H-, MS2M-H- and MS3(M-H)→base peak- data of phenolic compounds from  M. pulegium infusion a. 
Compoundsb Rt (min) UV (nm) M-H-, m/z MS2M-H-, m/z (%)  MS3, m/z (%) 
        
1 3-CaffQuin Ac 3.1 300sh, 328 353 191(100), 179(45)   
2 CaffPent 4.0 300sh, 328 311 179(65), 149(100)   
3 4-CaffQuin Ac 4.9 300sh, 328 353 173(100)   
4 Salv Ac H  10.3 252, 286, 314sh, 
344 
537 493(15), 339(100)  295(80), 229(100) 
5 Lut-7-Rut 11.1 256, 266sh, 348 593 285(100)   
6 Lut-7-Gluc 12.0 256, 266sh, 348 461 285(100)   
7 CaffHexPent 12.3 300sh, 328 473 311(100), 293(60), 179(10)  179(50), 149(100) 
8 Salv Ac E isomer 13.3 256, 284, 316, 348 717 519(100), 475(35)  475(100) 
9 Chrys/Diosmt-7-Rut 14.4 256, 268sh, 348 607 299(100), 284(30)   
10 Apig-7-Gluc 14.8 267, 337 445 400(10), 269(100)   
11 Rosm Ac 15.0 300sh, 328 359 197(30), 179(40), 161(100)   
12 FerHexPent 16.1 300sh, 328 487 325(100), 307(57), 293(85), 193(30)  193(100), 149(4) 
13 Lith Ac  17.1 298sh, 325 537 493(100), 359(35)c  359(100) 
14 Salv Ac C isomer 19.2 262, 320 491 311(100)   
15 Fer Rosm Ac  20.0 300sh, 328 535 359(90), 177(100)d   
a Main observed fragments. Other ions were found but they have not been included. 
b Ac: acid; Caff: caffeoyl; Fer: feruloyl; Quin: quinic; Pent: pentosyl; Hex: hexosyl; Gluc: glucuronoyl; Lut: luteolin; Apig: apigenin; Chrys: chrysoeriol; 
Diosmt:    diosmetin; Salv: salvianolic; Rosm: rosmarinic; Lith: lithospermic; Rut: rutinoside. 
c MS3(537→359): 197(40), 179(40), 161(100).   
d MS3(535→359): 197(20), 179(35), 161(100). 
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Compounds 4, 13 and 14 are trimmers. Compound 4 presented [M-H]- ion at m/z 537, 
losses of DSS (-198, m/z 339 base peak) and of a carbonyl group (-44) coincident with the 
fragmentation observed for salvianolic acid H (SAH) (87). In addition, its UV spectrum, 
different from those of the other caffeic acid derivatives above described, has already 
been reported (90). As for compound 13, an isomer of compound 4, an UV spectrum 
characteristic of caffeic acid derivatives was observed (Table 5). Both the similar MS 
fragmentation, showing a base peak corresponding to the loss of a carbonyl group (-44, 
m/z 493), and chromatographic mobility compared to rosmarinic acid were reported for 
lithospermic acid (88); therefore it was tentatively labelled as lithospermic acid. The last, 
compound 14, exhibited the same deprotonated molecular ion of salvianolic acid C (m/z 
491), also with the same chromatographic behavior, eluting at the end of the 
chromatogram. However, the loss of the DSS (-198) fragment with formation of the base 
peak reported before (88) was not observed; instead, the fragmentation originated the 
base peak at m/z 311 by loss of a caffeic acid moiety (-180), as reported in (90), either 
caused by different analytical conditions or by the presence of an isomer. Thus, it was 
tentatively labelled as salvianolic acid C isomer. 
Compound 8 is a tetramer ([M-H]- at m/z 717). Its MS fragmentation showed the loss 
of DSS, giving rise to the base peak (m/z 519), as reported for the tetramers salvianolic 
acids E, B and L (91). Nevertheless, taking into account its lower chromatographic 
mobility, compared with that of rosmarinic acid, and strong resemblance with the 
fragmentation pattern and UV spectrum of a salvianolic acid E isomer described before 
(90), compound 8 may correspond to this molecule. 
Other compounds with UV spectra of cinnamoyl derivatives were noticed at Rt 6.0 and 
15.3 min (Ac, Fig. 14), though their structures could not be determined. 
Finally, four other peaks (5, 6, 9 and 10) found in trace amounts and with UV and MS 
spectra of flavonoids were observed. Compounds 5, 6 and 9 presented an UV spectrum 
characteristic of flavones with di-substitution at the B ring (Table 5). The MS fragmentation 
of compounds 5 and 6 showed the ion at m/z 285 ([luteolin-H]-) as base peak, thus being 
identified as luteolin derivatives. Compound 5 fragmentation, with loss of 308 amu 
(rhamnohexosyl moiety) and without ions characteristic of interglycosyl linkage cleavage, 
suggested the presence of a rhamnosyl(1→6)hexoside linkage. As so, it was tentatively 
labelled as luteolin 7-O-rhamnosyl(1→6)glucoside (luteolin 7-O-rutinoside). Moreover, the 
loss of 176 amu (glucuronoyl moiety) by fragmentation of compound 6 led to its 
identification as luteolin 7-O-glucuronide. As it happened for compound 5, in the MS 
fragmentation of compound 9 it was observed the loss of 308 amu, resulting in the 
formation of the deprotonated aglycone ion (m/z 299), pointing to a methyl-luteolin, 
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probably chrysoeriol (5,7,4’-OH-3’-OMe-flavone, 3’-Me-luteolin) or diosmetin (5,7,3’-OH-
4’-OMe-flavone, 4’-Me-luteolin). Thus, compound 9 was tentatively labelled as 
chrysoeriol/diosmetin 7-O-rutinoside. Compound 10 was identified as apigenin 7-O-
glucuronide due to the UV spectrum characteristic of an apigenin derivative (Table 4) and 
because the fragmentation of its deprotonated molecular ion ([M-H]-, 445) resulted in the 
deprotonated molecular ion of apigenin ([apigenin-H]-, 269), the base peak, by loss of a 
176 amu fragment (glucuronoyl moiety). 
With the exceptions of rosmarinic and lithospermic acids and of diosmetin 7-O-
rutinoside, all the other 12 compounds were identified for the first time in M. pulegium 
species. 
2. HPLC-DAD quantitative analysis of phenolic compounds 
 
 The phenolic fraction of the infusion corresponded to 122.92 mg/g, distributed by 
the 15 identified compounds (Table 6). 
Table 6. Phenolic composition of M. pulegium infusion. 
Compoundsa  mg/g lyophilized infusionb 
   
1  4.16 ± 0.05 
2  2.44 ± 0.02 
3  2.64 ± 0.04 
4  7.60 ± 0.76 
5  0.64 ± 0.02 
6  1.40 ± 0.06 
7  16.20 ± 1.36 
8  1.88 ± 0.12 
9  3.40 ± 0.13 
10  1.32 ± 0.09 
11  66.08 ± 5.19 
12  3.48 ± 0.10 
13  7.52 ± 0.69 
14  1.84 ± 0.03 
15  2.24 ± 0.07 
   
Σc  122.92 
a Identity of compounds as in Table 5. 
b Results are expressed as means ± standard deviations of three independent determinations. 
c Sum of the quantified compounds. 
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 Phenolic acids represented 94% of the determined compounds. Rosmarinic acid 
(compound 11) was the main compound (54% of the quantified compounds), as expected 
for a Lamiaceae species, being followed by other cinnamoyl derivatives, namely caffeoyl 
hexosylpentoside (compound 7, 13%) and the trimmers salvianolic acid H (compound 4) 
and lithospermic acid (compound 13, 6%, each) (Table 6).  
As for the identified flavonoids, chrysoeriol/diosmetin 7-O-rutinoside (compound 9) 
was the most abundant one (3%).  
 
3. Antiradical activity 
 
 The antiradical potential of M. pulegium infusion was evaluated by three different 
methodologies, as preliminary screening preceding the cellular assays (Fig. 15).  
 
Figure 25. Antiradical activity of M. pulegium infusion against DPPH·, O2-· and ·NO radicals. 
  
Concentration-dependent responses were observed, although total scavenging 
activity was not reached for ·NO radical. The EC50 values obtained were of 23, 39 and 226 
µg/mL against DPPH·, O2·- and ·NO radicals, respectively.  
 A similar result was obtained in a previous work, in which the hot water extract 
revealed to be very effective against DPPH· (57). As for the other radicals, no previous 
results were found. As referred above, phenolic compounds are extremely effective in 
neutralizing radical species. Therefore, the results here obtained can be, at least partially, 
explained by the phenolic content of the tested infusion (Table 6). 
 Since ROS and RNS are directly and indirectly involved in some cellular oxidative 
stress mechanisms, dietary polyphenols intake may display an important role on 
balancing potential toxic environments. 
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4. Cellular viability and antioxidant protection against t-BHP induced toxicity 
 
 Originally, Caco-2 cells derive from human colon carcinoma and AGS cells from 
human gastric carcinoma. Both cell lines were selected for this study as models of cellular 
response to xenobiotics since, when consumed, M. pulegium infusion directly contacts 
with gastric and intestinal epithelia.  
 A preliminary experiment was conducted in order to assess the range of 
concentrations for which the exposure to the infusion was not able to affect cellular 
viability (Fig. 16). 
 
Figure 16. Effect of M. pulegium infusion on Caco-2 and AGS cell lines viability after 24 h of exposure, 
assessed by MTT reduction and LDH leakage assays. Values show mean ± SEM of six independent assays 
performed in triplicate (**p<0.01, ****p<0.0001 and #p<0.05 compared to the respective controls). 
  
When comparing the two cell lines, AGS cells demonstrated to be more sensitive, 
since viability started to significantly decrease when exposed to 0.31 mg/mL of infusion, 
while for Caco-2 this happened only at 1.25 mg/mL (Fig .16). Moreover the results 
obtained by the MTT reduction assay were more expressive than the ones by LDH 
leakage for both cell lines, thus suggesting that mitochondrial damage happens prior to 
membrane’s damage. 
 The following step was to evaluate the potential of M. pulegium infusion to protect 
the cells against the toxicity caused by t-BHP. This hydroperoxide is frequently applied to 
induce oxidative stress, the toxicity to hepatocytes being a result from either the 
metabolism through cytochrome p450 or reduction of GSH. As result, several biomarkers 
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can be monitored, like the increased levels of alanine transaminase, aspartate 
aminotransferase, LDH and malondialdehyde, and also GSH depletion (92).      
 t-BHP is reduced by GPx leading to the formation of t-butanol, with GSH depletion 
and increased GSSG:  
 
 Cytochrome p450 or Fe2+ and Fe3+ ions can also catalyze its transformation into 
alcoxyl and peroxyl radicals that can trigger lipid peroxidation process (92):  
 
 
Additionally, alterations in the intracellular calcium homeostasis, metal chelation 
and DNA strand breaks are also some phenomena underlying its toxicity (92)  
 In this work, cells were treated with M. pulegium infusion for 24 h prior to t-BHP 
exposure (0.5 mM, 6 h). Cellular viability was again determined by MTT reduction and 
LDH leakage assays (Fig. 17).  
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Figure 17. Caco-2 and AGS cellular viability assessed by MTT reduction and LDH leakage assays, after exposure to M. pulegium infusion, with and without t-BHP-induced 
toxicity. Cells were pre-treated with the infusion for 24 h. Insulted cells were further exposed to t-BHP (0.5 mM) for 6 h. , Values show mean ± SEM of six independent 
experiments performed in triplicate (***p<0.001, ****p<0.0001 and ##p<0.01, ####p<0.0001 compared to the respective controls). 
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 The infusion clearly exerted a dose-dependent protective effect in the MTT 
reduction assay. In fact, total protection, when compared to controls, was almost achieved 
with the infusion at the concentrations of 1.25 and 0.63 mg/mL for Caco-2 and AGS cells, 
respectively (Fig. 17), despite that at this concentrations the infusion induced cytotoxicity 
by itself (Fig. 16). Hence, it can be assumed that from the pre-treatment with the infusion 
and post exposure to the toxicant did not result a synergic toxic effect. 
 Contrarily to what was expected, an increase of LDH leakage was not observed in 
neither cell lines (Fig. 17). In a previous work using LDH leakage as a biomarker for 
necrosis, and DNA fragmentation as a biomarker for apoptosis, it was reported that a 
concentration of t-BHP of 0.4-0.5 mM provides a transition point below which apoptosis is 
favored and beyond which necrosis is favored (93). Taking this into consideration, it can 
be inferred that for the experimented t-BHP exposure conditions (0.5 mM, 6 hours) cell 
death was triggered by apoptosis, thus not being observed the increase of extracellular 
LDH, which is related with a cellular membrane damage.  
 The phenolic composition of M. pulegium infusion here reported (Table 5) can be 
implicated in the antioxidant protective effect observed. Other flavonoids, like rutin and 
quercetin, also tested in a similar pre-treatment experimental model, were very effective at 
preventing Caco-2 DNA damage induced by t-BHP (94). The authors attributed such 
results to the metal iron chelating and free radical scavenging properties of those 
compounds. With HepG2 cells, but using a co-exposition model, it was demonstrated that 
other phenolics like luteolin, quercetin, luteolin 7-O-glucoside, caffeic and rosmarinic acids 
also protected the cells against t-BHP, by preventing lipid peroxidation and GSH depletion 
(95).  
 
5. Total and oxidized GSH determination 
 
 Attempting to disclosure a possible mechanism behind the antioxidant activity 
observed, total glutathione (GSx) and GSSG levels were quantified under the same model 
of pre-treatment with the infusion, followed by t-BHP-induced toxicity (Fig. 18). 
 
 
 
 
Results and discussion 
 
68 
 
 
Figure 18. Total glutathione (GSx) and oxidized glutathione (GSSG) determination. Caco-2 and AGS cells were pre-treated with M. pulegium infusion for 24 h. GSx and 
GSSG levels were quantified with and without t-BHP exposure. Values show mean ± SEM of three independent assays performed in triplicate (**p<0.01***p<0.001 and 
****p<0.0001 compared to respective controls and ####p<0.0001 comparison with and without t-BHP).
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 The results revealed a different response of the two cell lines. In Caco-2 cells, no 
increase of GSx levels was observed when compared to respective controls without 
infusion treatment. However, when post-exposed to t-BHP, GSx levels increased very 
significantly in a concentration-dependent response for infusion concentrations above 
0.04 mg/mL (Fig. 18). This increase may be the result of a synergic effect over the ɣ-
glutamylcysteine synthetase enzyme, the rate limiting enzyme responsible for glutathione 
synthesis, which is known to be more active in response to cellular treatments with 
phenolic compounds, leading to de novo synthesis (28). As expected, after t-BHP 
exposure higher GSSG levels were observed when compared to the respective control, 
and it was demonstrated that the infusion was able to prevent GSH oxidation (Fig. 18). 
Taking together these results with the ones obtained for the MTT reduction assay (Fig. 
17), it can be noticed that the infusion prevented GSH oxidation even at concentrations at 
which it was not able to avoid cell death (0.04 to 0.16 mg/mL). As so, this mechanism is 
certainly important, but not the only one behind the protective effect observed.      
 In contrast, under the same experimental conditions, the infusion was not able to 
exert the same effect in AGS cells (Fig. 18). GSx levels were not significantly altered by 
neither the infusion nor the toxicant exposures. However, for the concentration of 0.31 
mg/mL, a significant decrease of the GSSG levels was observed (Fig. 18), in accordance 
with the verified viability increase (Fig. 17). The results indicate that for AGS cells, t-BHP 
reduction by GSH was not the most relevant toxicity mechanism. 
 
6. DPBA staining of intracellular polyphenols 
 
 DPBA is capable of binding to flavonoids and phenolic acids in reactive sites after 
the loss of an ethanolamine chain, with adduct formation and fluorescence emission (96). 
One of its applications is related to flavonoids staining in plant cells, to understand the 
mechanisms of their transport and to follow their localization (97).  
 To sustain if the phenolic compounds present in M. pulegium infusion were able to 
enter into the cells, a DPBA staining technique was applied. Nuclear staining with DAPI 
was also used to check on nuclear morphology. Based on the phenolic profile here 
reported, phenolic acids were the major represented class, rosmarinic acid being the one 
at the highest concentration (Table 5). So, in addition to the positive apigenin control (25 
µM), as described in a previous work (98), a rosmarinic acid control (25 µM) was also 
tested.     
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 The results showed that after 24 h of exposure to the infusion, the phenolic 
compounds could yet be targeted inside Caco-2 and AGS cells (Fig. 19). 
 
Figure 19. Fluorescence microscopy of intracellular DPBA staining of phenolic compounds and DAPI 
nuclear staining. Caco-2 and ÁGS cells were treated with M. pulegium infusion at the concentrations of 0.31 
and 0.16 mg/mL, respectively, for 24 h. Three independent experiments were performed, and a representative 
field was selected. 
  
Based on the positive controls, the detected fluorescence was derived by DPBA 
linkage to flavonoids and phenolic acids (Fig. 19). In agreement with the results reported 
in a previous work with leukemia cells (98), when incubated with apigenin, AGS and 
Infusion
DAPI DPBA
Control
Apigenin
Rosmarinic
acid
AGS
DAPI DPBA
Caco-2
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Caco-2 cells seem to undergo an apoptotic process where chromatin condensation and 
vacuolization are clearly observed (Fig. 19).  
 As for rosmarinic acid controls, in comparison to the respective negative controls 
some slight morphological alterations can be observed, but in a smaller scale when 
compared to apigenin (Fig. 19). It has been reported that despite its antioxidant 
properties, rosmarinic acid can also act as antiproliferative and as an apoptotic inducer 
agent (99-101).  
 The viability assays did not demonstrate cellular toxic effects for the experimented 
infusion concentrations (Fig. 16). However, nuclear morphology alterations may be earlier 
visible than other toxicological end-points. 
 This works also sustained that the phenolic compounds were capable to pass 
through the cellular membrane, even without prior hydrolyses. More important, since the 
protective effect was observed under a pre-treatment model, the phenolic compounds 
were still inside the cells when exposed to t-BHP. Besides GSH defenses, phenolic 
compounds might also act directly over the toxicant. 
 As far as we know, no previous work focusing intracellular phenolic compounds 
staining and related antioxidant potential, of neither isolated compounds nor herbal 
extracts, in Caco-2 and AGS cells was performed.     
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Chapter V - Conclusions 
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 With this work it was established for the first time the phenolic profile of M. 
pulegium infusion. Also, 12 new compounds were identified for the first time in this 
species. Rosmarinic acid was the major compound. The chemical profile found supports 
the very effective scavenging activity against DPPH·, ·NO and O2·- radicals. The infusion 
demonstrated to protect Caco-2 and AGS cells against t-BHP-induced toxicity, in a 
concentration-dependent manner, probably due to GSH induction and prevention of 
GSSG formation. It was also demonstrated that, even being glycosylated, the phenolic 
compounds were able to pass through the cellular membrane and act as direct 
antioxidants. 
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